Harvard, Psychedelics – From Beecher to Leary (1954–1960)

Harvard, Psychedelics, and the Bridge from Beecher to Leary (1954–1960)

Beezone

Harvard Square – Photo by Ed Reither

Introduction

The modern history of psychedelics at Harvard is usually told as a story beginning in 1960, when Timothy Leary ingested psilocybin mushrooms in Cuernavaca and returned to Cambridge to launch the Harvard Psilocybin Project. But the university’s engagement with psychedelics began earlier. Between 1954 and 1960, Harvard hosted two radically different but ultimately converging approaches to mind-altering substances: the clinical pharmacology of Henry K. Beecher at Harvard Medical School and the ethnomycological discoveries of R. Gordon Wasson, whose work inspired the imagination of psychologists like Leary.

Timothy Leary and Richard Alpert (Ram Dass), 1960

 

Leary’s psilocybin project, as Ed Reither has written, was “an outgrowth and emergence of a scientific, religious, psychological, philosophical, and cultural evolution” that had been unfolding at Harvard for decades. To understand Leary, we must first understand Beecher — and the intellectual ground already prepared by the university itself.

Beecher’s LSD Laboratory: Harvard Medical School, 1954–1956

Henry K. Beecher, Harvard’s first endowed professor of anesthesiology, was a key figure in the post-war transformation of American medical science. Best known for his studies on placebo and his later role in founding modern bioethics, Beecher was also one of America’s first LSD researchers.

In the mid-1950s, together with John von Felsinger and Louis Lasagna, Beecher conducted a series of controlled experiments on LSD and lysergic acid monoethylamide (LAE), culminating in the 1956 article “The Response of Normal Men to Lysergic Acid Derivatives” in the Journal of Clinical and Experimental Psychopathology. These studies, conducted under contract with the U.S. Army’s Medical Research and Development Board, administered hallucinogens to healthy male volunteers and assessed their responses through Rorschach tests, psychiatric interviews, and physiological monitoring.

The conclusions were pivotal: LSD did not produce a uniform psychosis. Instead, it amplified pre-existing personality traits and emotional states. Anxious subjects became more anxious; stable individuals reported more controlled and even insightful experiences. As Beecher’s team summarized, “The drug effect was determined less by the pharmacology than by the subject’s own psychic structure.” This was the first articulation, in clinical terms, of what Leary would later popularize as “set and setting.”

Beecher’s work was not simply academic. His LSD research was funded by the Army and viewed within the frame of Cold War concerns about “truth serums” and psychological control. As George Mashour has shown, Beecher’s anesthesia lab became a site of classified research, and his team was consulted on questions of interrogation and resistance. The same man who would become the moral conscience of medical research ethics had begun by probing the psychological effects of hallucinogens for the U.S. military.

From LSD to Ethics

Beecher’s early hallucinogen work also shaped his later career as the most prominent voice for research ethics in American medicine. As Mashour notes, Beecher’s LSD studies reflected his lifelong interest in the subjective dimension of pharmacology — the way that environment, expectation, and personality could influence drug effects. This same insight led him to see the power of the placebo effect and to argue, in his landmark 1966 NEJM article “Ethics and Clinical Research,” that the quality of a study was not only in its data but in its moral design.

Beecher’s 1956 LSD paper thus marks the beginning of a line that would lead both to modern psychopharmacology and modern bioethics. He recognized that drugs like LSD were not just chemical agents but mirrors of the mind, and that the conditions under which they were given mattered as much as the molecules themselves.

Wasson’s Ethnomycology: Mushrooms and the Sacred Past (1957–1959)

While Beecher was conducting laboratory studies at Harvard Medical School, a radically different psychedelic narrative was emerging. In 1957, R. Gordon Wasson — a banker, amateur mycologist, and ethnographer — published his famous Life magazine article “Seeking the Magic Mushroom,” detailing his participation in a Mazatec mushroom ceremony in Oaxaca. By 1959, in his lecture “Adventure in Ethnomycological Exploration,” Wasson had introduced the term ethnomycology and argued that sacred mushrooms were the remnants of a lost sacramental tradition.

Working with French mycologist Roger Heim and Swiss chemist Albert Hofmann (who had discovered LSD), Wasson helped identify the mushrooms as Psilocybe mexicana, isolate their active ingredient (psilocybin), and send it to Sandoz Laboratories, which synthesized it as Indocybin. But Wasson’s focus was not pharmacological. He emphasized the religious and cultural significance of these mushrooms. They were, he argued, “God’s flesh” (teonanácatl), sacraments of vision linked to the Eleusinian Mysteries, Vedic Soma, and the Christian Eucharist.

Wasson’s ethnomycology brought psychedelics into Harvard’s orbit not through the laboratory but through myth, anthropology, and religion. His work inspired theologians, psychologists, and philosophers to consider the possibility that hallucinogens were not simply psychotomimetic agents but catalysts of mystical experience.

Harvard’s Intellectual Ground: William James to Social Relations

By the late 1950s, Harvard already had a long tradition of exploring altered states. William James, in the 1890s, had experimented with nitrous oxide and ether, claiming to have glimpsed “metaphysical illumination” and urging others to try it. His Varieties of Religious Experience became a touchstone for later researchers. Morton Prince, founder of the Center for Personality Research, had explored hypnosis, trance, and dissociation in the early 20th century.

In the 1940s, Harvard’s Department of Social Relations was created as a bold interdisciplinary experiment, bringing together sociology, anthropology, and psychology. Figures like Henry Murray and David McClelland emphasized personality, symbolism, and meaning — creating an intellectual environment more open to subjective experience and symbolic transformation than the behaviorist mainstream.

By the time Timothy Leary arrived in 1959, Harvard was thus already primed — institutionally and intellectually — to consider altered states of consciousness as legitimate subjects of inquiry.

Leary’s Inheritance: The Harvard Psilocybin Project (1960–1963)

Timothy Lear, David McCelland, Richard Alpert (Ram Dass) 1983 Reunion – Harvard University.

Timothy Leary’s first experience with psilocybin mushrooms in Cuernavaca in the summer of 1960 was, in his words, the most profound religious experience of his life. Returning to Harvard, he joined the Center for Research in Personality, where he and Richard Alpert launched the Harvard Psilocybin Project.

Timothy Leary and IFIF Group, Mexico, 1963

Drawing on Beecher’s insight — that psychedelics amplify inner states — and Wasson’s vision — that they are sacraments — Leary reframed psilocybin as a consciousness-expanding substance. Rejecting the clinical detachment of psychiatry, he and Alpert designed their studies to be existential and transactional. They administered psilocybin to graduate students, artists, clergy, and even prison inmates, often in comfortable, supportive settings rather than sterile laboratories.

Over three years, the project documented nearly 400 sessions. Participants filled out questionnaires, wrote detailed reports, and engaged in group reflections. Leary and Alpert emphasized that set (mindset) and setting (environment) were crucial to the outcome — echoing Beecher’s earlier clinical finding but expanding it into a theory of transformation.

As Reither notes, “the major insight that emerged was that the psilocybin experience, when guided properly, could lead to a heightened state of awareness, improved interpersonal relationships, and even mystical experiences”. Leary saw psilocybin not as a drug in the narrow sense but as a tool for psycho-spiritual growth.

Conflict and Collapse

Harvard’s administration was not prepared for the direction the project took. Faculty members in the Department of Social Relations grew concerned that graduate students felt pressured to participate. Psychology professor Herbert Kelman reported that students believed psilocybin use had become “legitimized” to the point of expectation. Robert Rosenthal, who arrived just after Leary’s departure, remarked that it was “shocking” that Leary had made psychedelic use “a requirement.”

The controversy reflected a deeper institutional divide: between those, like Beecher, who believed research must be controlled, ethical, and institutionally sanctioned, and those, like Leary, who believed psychedelics could only be understood through direct experience and existential transformation. As Reither puts it, “The differences between those who wanted to explore new brain terrain and those who reflexively avoided the challenge foreshadowed the bitter cultural conflict that raged everywhere in the decade to come”.

By 1963, Harvard had severed ties with both Leary and Alpert. The Harvard Psilocybin Project became the first casualty of the coming “War on Drugs,” but also the first seed of a cultural revolution.

Conclusion: Harvard’s Double Legacy

Between 1954 and 1960, Harvard hosted two foundational but divergent psychedelic traditions:

  • Beecher’s LSD studies: rooted in medical science, funded by the military, ethically formative, emphasizing the amplification of personality and the importance of set and setting.

  • Wasson’s ethnomycology: rooted in anthropology and religion, emphasizing the sacred history and symbolic depth of psychedelic plants.

  • Leary’s Psilocybin Project: fusing both — the clinical insight of Beecher and the sacramental vision of Wasson — into a radical cultural experiment that reshaped the meaning of psychedelics for a generation.

As Ed Reither observes, “Harvard’s psychedelic research was an outgrowth and emergence of a scientific, religious, psychological, philosophical, and cultural evolution”. Leary did not begin that story; he inherited it — and transformed it. Beecher gave Harvard its first psychedelic laboratory; Wasson gave it its sacramental imagination; Leary gave it its cultural fire.

Today, as Harvard once again engages with psychedelic research, this history is more than a cautionary tale. It is a reminder that the intersection of science, spirituality, and culture — so alive at Harvard between 1954 and 1960 — still defines the field.

References

  • Henry K. Beecher, John von Felsinger, Louis Lasagna, The Response of Normal Men to Lysergic Acid Derivatives, Journal of Clinical and Experimental Psychopathology (1956), via Jonathan D. Moreno, Acid Brothers: Henry Beecher, Timothy Leary, and the Psychedelic of the Century (2016).

  • George A. Mashour, Altered States: LSD and the Anesthesia Laboratory of Henry Knowles Beecher, Bulletin of Anesthesia History 23:3 (2005).

  • R. Gordon Wasson, Adventure in Ethnomycological Exploration (1959).

  • Ed Reither, The Harvard Psilocybin Project 1960–1963 (book chapters and course material, 2023).